Earnings Alerts

Maximize Your Portfolio: People’s Insurance (PICC) (1339) Earnings Grow with 460.93B Yuan P&C Premiums

By November 14, 2024 No Comments
  • PICC Group reported year-to-date property and casualty insurance premium income totaling 460.93 billion yuan.
  • The year-to-date life insurance premium income for PICC Group reached 99.78 billion yuan.
  • Current analysis shows 11 buy recommendations for PICC Group.
  • There are 6 hold recommendations for the company.
  • No sell recommendations have been reported for PICC Group at this time.

A look at People’s Insurance (PICC) Smart Scores

FactorScoreMagnitude
Value5
Dividend5
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE4.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on Smartkarma Smart Scores, People’s Insurance Company (PICC) is positioned for a positive long-term outlook. The company excels in value and dividend factors, scoring the highest possible rating of 5 in both categories. This indicates that PICC is considered a reliable investment in terms of value and dividend returns.

Additionally, with strong scores in growth and momentum at 4 and 5 respectively, People’s Insurance shows promising signs of potential growth and market momentum. Although resilience scores slightly lower at 3, the overall Smart Score suggests a favorable outlook for People’s Insurance (PICC), making it an attractive option for those considering long-term investments.

The People’s Insurance Company (Group) of China Limited, through its subsidiaries, offers a range of property and casualty insurance products. The Company also offers asset management services for a variety of customers throughout China.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars